1st Quarter - Report
BIOMERIEUX for BIOMERIEUX
Firm
Client
Income
—
Expenses
$190,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Tariff (miscellaneous tariff bills) TAR
Discussions regarding tariff proposals
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL HARTMAN | — |
| JOHN RICHTER | — |
Budget/Appropriations BUD
Discussions regarding Veterans Affairs Appropriations Discussions regarding Indian Health Services Appropriations
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL HARTMAN | — |
| JOHN RICHTER | — |
Health Issues HCR
Issues regarding womens health Equitable Community Access to Pharmacists Services Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL HARTMAN | — |
| JOHN RICHTER | — |
Medical/Disease Research/Clinical Labs MED
Discussions regarding PASTEUR Act, the RESULTS Act, CLIA Modernization, and antimicrobial resistance.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL HARTMAN | — |
| JOHN RICHTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.